Unibest
← Back to patent-cliff list

CAS 151266-23-8

3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine

Codes: IBRT-010, (Xc)461018-4-a, (IVa)461018-8-a, (V)461018-11-a, (IIIb)461018-12-a, (VIII)461018-21-a

Application context (from source-drug indications)

Waldenström macroglobulinaemiaIbrutinibChronic lymphocytic leukaemiaIbrutinibMantle cell lymphomaIbrutinibGraft-versus-host diseaseIbrutinib

Source drugs (routes using this intermediate)

DrugTierExpiry
IbrutinibTier A — Act now2027

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works3-iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Qualified Partner — East China API Works4-Amino-3-iodopyrazolo[3,4 -d]pyrimidine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Nantong cGMP Site3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—
Unibest Taizhou GMP-like Site3-Iodo-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.